Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity
Top Cited Papers
- 30 April 2010
- journal article
- research article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 8 (4), 357-363
- https://doi.org/10.1016/j.cgh.2010.01.001
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Certolizumab Pegol for the Treatment of Crohn's DiseaseThe New England Journal of Medicine, 2007
- Maintenance Therapy with Certolizumab Pegol for Crohn's DiseaseThe New England Journal of Medicine, 2007
- Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978???2002European Journal of Gastroenterology & Hepatology, 2006
- Predicting the Crohnʼs disease activity index from the harvey-bradshaw indexInflammatory Bowel Diseases, 2006
- A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s DiseaseGastroenterology, 2005
- Open label trial of oral clarithromycin in active Crohn’s diseaseAlimentary Pharmacology & Therapeutics, 2000
- Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).Gut, 1996
- Methotrexate for the treatment of refractory Crohn's disease.Alimentary Pharmacology & Therapeutics, 1996
- A Controlled Double Blind Multicenter Study of the Effectiveness of 5-Aminosalicylic Acid in Patients with Crohnʼs Disease in RemissionJournal of Clinical Gastroenterology, 1995
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980